Kevin Joseph Fitzgerald, CSO & EVP, Head of Research: Alnylam Pharmaceuticals ALNY Sell · Filed 25/02/18

Trade details

Type: Insider sale
Amount: $271,728.06
Shares · price: 1,086 sh · $250.21 a share
Held after: 13,235 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Trade date: 25/02/18
Filed: 25/02/18
Days to filing: 0 days

Sold 7.6% of holdings

Share of holding sold: 7.6%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Kevin Joseph Fitzgerald's recent trades

Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$75.3K
233 sh
$75.3K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$68K
210 sh
$68K
Filed 03/06
Traded 03/04
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$49.9K
153 sh
$49.9K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$48K
148 sh
$48K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$39.9K
124 sh
$39.9K
Filed 03/06
Traded 03/05

Kevin Joseph Fitzgerald, EVP — sold $271.7K of Alnylam Pharmaceuticals ALNY · 7.6% of holdings · 10b5-1 plan | Whalegun